HomeNVCT • NASDAQ
add
Nuvectis Pharma Inc
Previous close
$9.35
Day range
$9.15 - $9.54
Year range
$4.44 - $11.80
Market cap
222.40M USD
Avg Volume
152.54K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 5.57M | 26.66% |
Net income | -5.33M | -27.84% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 29.86M | 53.43% |
Total assets | 30.15M | 52.93% |
Total liabilities | 9.19M | 61.52% |
Total equity | 20.95M | — |
Shares outstanding | 23.63M | — |
Price to book | 10.51 | — |
Return on assets | -57.10% | — |
Return on capital | -90.78% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -5.33M | -27.84% |
Cash from operations | -4.17M | 4.22% |
Cash from investing | — | — |
Cash from financing | 15.50M | 230.17% |
Net change in cash | 11.33M | 3,252.37% |
Free cash flow | -1.99M | 32.09% |
About
Founded
2020
Headquarters
Website
Employees
13
